At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Ropivacaine (sciatic nerve block) +2 moredrug
Likely dose
Ropivacaine (sciatic nerve block) 20 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Surgical Treatment of Proximal Femoral Fractures Under Peripheral Regional Anesthesia. A Prospective Pilot Study
In Brief
A clinical study evaluating Ropivacaine (sciatic nerve block), Ropivacaine (lumbar plexus block L2-L4), and 1 other intervention for Hip Fractures. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The study investigates whether treatment of proximal femoral fractures is possible using a peripheral regional anesthesia technique.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip Fractures
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartAug 2019
Primary CompletionJun 2020
Study CompletionJun 2020
TodayJul 2026
First PostedJul 2, 2019
Enrollment StartAug 5, 2019
Primary CompletionJun 29, 2020
Study CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7 years ago
Interventions
Ropivacaine (sciatic nerve block)drug
injection of 20 ml ropivacaine 0.375%
Ropivacaine (lumbar plexus block L2-L4)drug
injection of 20 ml ropivacaine 0.375%
Ropivacaine (lumbar plexus block Th12-L1)drug
injection of 20 ml ropivacaine 0.375%